Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totaling 150,845 shares, a decrease of 24.5% from the December 15th total of 199,691 shares. Based on an average trading volume of 75,100 shares, the days-to-cover ratio is currently 2.0 days. Currently, 0.8% of the shares of the company are short sold. Currently, 0.8% of the shares of the company are short sold. Based on an average trading volume of 75,100 shares, the days-to-cover ratio is currently 2.0 days.

Basel Medical Group Stock Down 0.1%

Shares of NASDAQ:BMGL traded down $0.00 on Friday, reaching $0.83. 21,456 shares of the company’s stock were exchanged, compared to its average volume of 60,221. The business’s 50-day moving average is $0.90 and its two-hundred day moving average is $1.57. Basel Medical Group has a fifty-two week low of $0.49 and a fifty-two week high of $9.40.

Basel Medical Group (NASDAQ:BMGL) last released its quarterly earnings data on Monday, November 17th. The company reported ($0.25) earnings per share for the quarter. The business had revenue of $2.60 million for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Basel Medical Group in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Marex Group plc purchased a new position in Basel Medical Group during the 2nd quarter valued at approximately $25,000. Vanguard Personalized Indexing Management LLC acquired a new stake in Basel Medical Group during the third quarter worth about $40,000. Virtu Financial LLC raised its stake in shares of Basel Medical Group by 108.8% during the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after buying an additional 17,608 shares during the period. Finally, Citadel Advisors LLC purchased a new position in Basel Medical Group in the 3rd quarter valued at $169,000.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.